Yasue Horiuchi

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 9

Top Topics

Cognitive Impairment

Genome Wide Association Study

Bipolar Disorder

Top Venues

Translational psychiatry

EMBO molecular medicine

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, Emmanuel Shan Onaivi
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders. International journal of molecular sciences 23 (2) (2022)
Akane Yoshikawa, Itaru Kushima, Mitsuhiro Miyashita, Kazuhiro Suzuki, Kyoka Iino, Kazuya Toriumi, Yasue Horiuchi, Hideya Kawaji, Norio Ozaki, Masanari Itokawa, Makoto Arai
Exonic deletions in IMMP2L in schizophrenia with enhanced glycation stress subtype. PloS one 17 (7) (2022)
Mitsuhiro Miyashita, Syudo Yamasaki, Shuntaro Ando, Kazuhiro Suzuki, Kazuya Toriumi, Yasue Horiuchi, Akane Yoshikawa, Atsushi Imai, Yukihiro Nagase, Yasuhiro Miyano, Tomoko Inoue, Kaori Endo, Yuko Morimoto, Masaya Morita, Tomoki Kiyono, Satoshi Usami, Yuji Okazaki, Toshiaki A Furukawa, Mariko Hiraiwa-Hasegawa, Masanari Itokawa, Kiyoto Kasai, Atsushi Nishida, Makoto Arai
Fingertip advanced glycation end products and psychotic symptoms among adolescents. NPJ schizophrenia 7 (1) (2021)
Akane Yoshikawa, Itaru Kushima, Mitsuhiro Miyashita, Kazuya Toriumi, Kazuhiro Suzuki, Yasue Horiuchi, Hideya Kawaji, Shunya Takizawa, Norio Ozaki, Masanari Itokawa, Makoto Arai
Dysregulation of post-transcriptional modification by copy number variable microRNAs in schizophrenia with enhanced glycation stress. Translational psychiatry 11 (1) (2021)
Kazuya Toriumi, Mitsuhiro Miyashita, Kazuhiro Suzuki, Nao Yamasaki, Misako Yasumura, Yasue Horiuchi, Akane Yoshikawa, Mai Asakura, Noriyoshi Usui, Masanari Itokawa, Makoto Arai
Vitamin B6 deficiency hyperactivates the noradrenergic system, leading to social deficits and cognitive impairment. Translational psychiatry 11 (1) (2021)
Tetsuo Ohnishi, Yuji Kiyama, Fumiko Arima-Yoshida, Mitsutaka Kadota, Tomoe Ichikawa, Kazuyuki Yamada, Akiko Watanabe, Hisako Ohba, Kaori Tanaka, Akihiro Nakaya, Yasue Horiuchi, Yoshimi Iwayama, Manabu Toyoshima, Itone Ogawa, Chie Shimamoto-Mitsuyama, Motoko Maekawa, Shabeesh Balan, Makoto Arai, Mitsuhiro Miyashita, Kazuya Toriumi, Yayoi Nozaki, Rumi Kurokawa, Kazuhiro Suzuki, Akane Yoshikawa, Tomoko Toyota, Toshihiko Hosoya, Hiroyuki Okuno, Haruhiko Bito, Masanari Itokawa, Shigehiro Kuraku, Toshiya Manabe, Takeo Yoshikawa
Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia. EMBO molecular medicine 13 (4) (2021)
Yoichiro Takayanagi, Koko Ishizuka, Thomas M Laursen, Hiroshi Yukitake, Kun Yang, Nicola G Cascella, Shuhei Ueda, Akiko Sumitomo, Zui Narita, Yasue Horiuchi, Minae Niwa, Akiko Taguchi, Morris F White, William W Eaton, Preben B Mortensen, Takeshi Sakurai, Akira Sawa
From population to neuron: exploring common mediators for metabolic problems and mental illnesses. Molecular psychiatry 26 (8) (2020)
Yasue Horiuchi, Tomoe Ichikawa, Tetsuo Ohnishi, Yoshimi Iwayama, Kazuya Toriumi, Mitsuhiro Miyashita, Izumi Nohara, Nanako Obata, Tomoko Toyota, Takeo Yoshikawa, Masanari Itokawa, Makoto Arai
LDB2 locus disruption on 4p16.1 as a risk factor for schizophrenia and bipolar disorder. Human genome variation 7 (2020)
Yoshimi Kiyozumi, Hiroyuki Matsubayashi, Satomi Higashigawa, Yasue Horiuchi, Nobuhiro Kado, Yasuyuki Hirashima, Akio Shiomi, Takuma Oishi, Sumiko Ohnami, Keiichi Ohshima, Kenichi Urakami, Takeshi Nagashima, Ken Yamaguchi
Role of Tumor Mutation Burden Analysis in Detecting Lynch Syndrome in Precision Medicine: Analysis of 2,501 Japanese Cancer Patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (1) (2020)